Together with our results this indicates that a potent lysyl oxidase inhibitor or therapeutic modulation of lysyl oxidase activity could serve a double purpose in the management of cancer, by simultaneously reducing malignancy of tumors and improving sensitivity towards concomitant treatment with anti-neoplastic drugs. Here, LOX is linked to cancer.